# Establishment of qualitative human immunodeficiency virus type 1 nucleic acid amplification test as an adjunct confirmatory test in low-prevalence areas and small- and medium-sized diagnostic laboratories

**Authors:** Shigeru Kusagawa, Ai Kawana-Tachikawa, Saori Matsuoka

PMC · DOI: 10.1016/j.heliyon.2024.e24451 · 2024-01-13

## TL;DR

The paper introduces two affordable and effective in-house HIV-1 nucleic acid tests to confirm HIV cases in low-prevalence areas and smaller labs.

## Contribution

Development of two simple, low-cost in-house HIV-1 NATs for use in small- and medium-sized labs and low-prevalence regions.

## Key findings

- Both tests detected most HIV-1 subtypes and circulating recombinant forms with high sensitivity.
- One test missed two group O samples, but both effectively confirmed HIV-1 antigen-positive cases.
- The tests help reduce false positives and are suitable for low-prevalence areas.

## Abstract

Two simple and inexpensive in-house qualitative human immunodeficiency virus type 1 nucleotide amplification tests (HIV-1 NATs) were established as adjunct confirmatory HIV test for HIV antigen (Ag)-positive specimens identified from HIV screening test and for patients with indeterminate or negative HIV antibody (Ab) confirmatory test results. The limit of detection was <1000 copies/mL, which is lower than that of the HIV Ag/Ab combination assay. One test using QL1 detected all 11 HIV-1 subtypes/circulating recombinant forms/group samples with almost equal analytical sensitivity, and the other test, using QL2, also detected all, except for two group O samples. In the examination of 28 HIV-1 Ag-positive samples using Determine HIV Early Detect, 27 samples were reactive and one HIV-1 Ag-pseudo-positive sample was non-reactive using both methods. These in-house qualitative HIV-1 NATs are useful for confirming HIV-1 Ag-positive cases and excluding HIV-1 Ag false-positive cases in areas with low HIV prevalence and small- and medium-sized diagnostic laboratories.

•Immunochromatography assay is important for expansion of HIV test opportunities.•Immunochromatography assay detects anti-HIV antibody and HIV-1 antigen separately.•Inexpensive HIV confirmatory test for HIV-1 antigen-positive cases is required.•Limit of detection of conventional RT-PCR is enough for HIV-1 antigen-positive cases.•Conventional RT-PCR is accustomed for small- and medium-sized diagnostic laboratories.

Immunochromatography assay is important for expansion of HIV test opportunities.

Immunochromatography assay detects anti-HIV antibody and HIV-1 antigen separately.

Inexpensive HIV confirmatory test for HIV-1 antigen-positive cases is required.

Limit of detection of conventional RT-PCR is enough for HIV-1 antigen-positive cases.

Conventional RT-PCR is accustomed for small- and medium-sized diagnostic laboratories.

## Full-text entities

- **Genes:** GLB1 (galactosidase beta 1) [NCBI Gene 2720] {aka EBP, ELNR1, MPS4B}
- **Diseases:** Infection (MESH:D007239), AIDS (MESH:D000163), CRFs (MESH:C535296), HIV (MESH:D015658), Infectious Diseases (MESH:D003141), COVID-19 (MESH:D000086382)
- **Species:** Human immunodeficiency virus 2 (no rank) [taxon 11709], Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus (species) [taxon 12721], Human immunodeficiency virus 1 (no rank) [taxon 11676]
- **Cell lines:** MAGIC5 — Mus musculus (Mouse), Transformed cell line (CVCL_5U93), MT2 — Homo sapiens (Human), Transformed cell line (CVCL_2631)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10831601/full.md

---
Source: https://tomesphere.com/paper/PMC10831601